2003
DOI: 10.1016/s0168-3659(03)00196-2
|View full text |Cite
|
Sign up to set email alerts
|

Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
26
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 56 publications
(28 citation statements)
references
References 31 publications
2
26
0
Order By: Relevance
“…These results suggested that RSM-S successfully predicted the relationship between the causal factors (formulation characteristic and formulation factors) and pharmaceutical response variables. 6,7) These results indicated that an original optimal solution with acceptable characteristics (e.g., high skin permeability and good stability formulation) could be estimated with RSM-S.…”
Section: Prediction Of Response Variables and Simultaneous Optimizationmentioning
confidence: 81%
See 1 more Smart Citation
“…These results suggested that RSM-S successfully predicted the relationship between the causal factors (formulation characteristic and formulation factors) and pharmaceutical response variables. 6,7) These results indicated that an original optimal solution with acceptable characteristics (e.g., high skin permeability and good stability formulation) could be estimated with RSM-S.…”
Section: Prediction Of Response Variables and Simultaneous Optimizationmentioning
confidence: 81%
“…RSM-S was determined to be a promising technique for formulation optimization. [3][4][5][6][7] Simultaneously, it is considerable to evaluate the accuracy and reliability of each optimal formulation estimated by RSM-S. The leave-one-out-cross-validation (LOOCV) method was also employed.…”
mentioning
confidence: 99%
“…There have been great progresses in implant devices for protein delivery (115)(116)(117)(118)(119)(120). Mohl and Winter developed a triglyceride implant aiming for sustained protein (115,116).…”
Section: Implantable Devices For Protein Deliverymentioning
confidence: 99%
“…Integrating hydroxypropyl-β-cyclodextrin into the matrices proved to stabilize IFNα-2a and led to a higher and faster protein release due to solubilizing effects. Surini et al designed an implantable controlled-release system based on a polyion complex device composed of chitosan and sodium hyaluronate for protein delivery (117). Insulin release from chitosan-hyaluronate pellets was markedly influenced by both the change in the polymer mixing ration and the total pellet weight, whereas the compression pressure did not affect the release profile significantly.…”
Section: Implantable Devices For Protein Deliverymentioning
confidence: 99%
“…More recently, the protein was bioengineered for use in biomaterials as three-dimensional porous scaffolds for tissue engineering (Kim et al, 2005), coating material for sustained drug release (Wang et al, 2007a;Bayraktar et al, 2005) and microspheres for encapsulation as drug carrier systems (Wang et al, 2007b) and films (Hofmann et al, 2006) for controlled drug delivery. On the other hand, hyaluronic acid (HA), a naturally occurring lubricous biopolymer, is an attractive building block for novel biocompatible and biodegradable biomaterials with potential applications in drug delivery (Surini et al, 2003;Luo et al, 2000;Simon et al, 1997) and tissue engineering (Park et al, 2002). HA has been used in the production of artificial blood vessel and artificial skin (Choi et al, 1999;Nishida et al, 1993), whereas electrical sensitive behavior of chitosan/hyaluronic acid polyelectrolyte complexes (PEC) has been found promising for the electric current mediated drug delivery systems (Kim et al, 2003).…”
Section: Introductionmentioning
confidence: 99%